test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 0.87%
1.41%
$44.283M
4.096M shares@ $10.81 avg price
MNMDMind Medicine Mindmed Inc
Recent Activity
Increased 15.75%
1.28%
$40.2M
7.065M shares@ $5.69 avg price
KURAKura Oncology Inc
Recent Activity
Increased 410.33%
1.22%
$38.367M
1.964M shares@ $19.55 avg price
CYTKCytokinetics Inc
Recent Activity
Increased 375.42%
1.06%
$33.259M
629,906 shares@ $52.81 avg price
ANIPAni Pharmaceuticals Inc
Recent Activity
Increased 8.32%
0.96%
$30.118M
504,828 shares@ $59.66 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Increased 490.47%
0.94%
$29.373M
1.101M shares@ $26.7 avg price
KRROKorro Bio Inc
Recent Activity
Increased 10.3%
0.91%
$28.407M
850,000 shares@ $33.42 avg price
ETNB89bio Inc
Recent Activity
Increased 20.6%
0.65%
$20.472M
2.767M shares@ $7.41 avg price
ENGNEngene Holdings Inc
Recent Activity
Increased 15.9%
0.55%
$17.21M
2.608M shares@ $6.61 avg price
NMRANeumora Therapeutics Inc.
Recent Activity
Increased 314.37%
0.32%
$9.88M↑ Call
747,928 shares@ $13.22 avg price